Filovirus vaccine (AlphaVax)(Filovirus vaccine (AlphaVax)) - 在研适应症：丝状病毒感染_专利_临床

概要

基本信息

药物类型

预防性疫苗

别名

Filovirus (AlphaVax)

靶点-

作用机制-

治疗领域

感染

在研适应症

丝状病毒感染

非在研适应症-

原研机构

AlphaVax, Inc.

在研机构

AlphaVax, Inc.

非在研机构-

最高研发阶段临床前

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

100 项与 Filovirus vaccine (AlphaVax) 相关的临床结果

登录后查看更多信息

100 项与 Filovirus vaccine (AlphaVax) 相关的转化医学

登录后查看更多信息

100 项与 Filovirus vaccine (AlphaVax) 相关的专利（医药）

登录后查看更多信息

1

项与 Filovirus vaccine (AlphaVax) 相关的文献（医药）

npj Vaccines

Filovirus vaccines as a response paradigm for emerging infectious diseases

Review

作者: Feldmann, Heinz ; Marzi, Andrea

AbstractNowadays, filovirus vaccine development may be seen as a paradigm for our response capabilities to emerging and re-emerging infectious diseases. Specifically, the West African Ebola virus disease (EVD) epidemic accelerated countermeasure licensure for several vaccine and therapeutic products. Those products have been successfully used to control EVD outbreaks in Central Africa over the past years. This positive development, however, has not yet reached beyond EVD. Therefore, it is pertinent to increase our efforts in the development of countermeasures for other human pathogenic members of the family Filoviridae as they continue to threaten public health in Sub-Saharan Africa. This review article summarizes the current filovirus vaccines in preclinical macaque studies and human clinical trials and discusses the most promising recent advancements.

100 项与 Filovirus vaccine (AlphaVax) 相关的药物交易

登录后查看更多信息